| MLC | minimum lethal concentration; mixed leukocyte culture; mixed ligand chelate; mixed lymphocyte concen... |
|---|---|
| MIF | macrophage inhibitory factor; melanocyte[-stimulating hormone]-inhibiting factor; maximum inspirator... |
| MMMT | malignant mixed mullerian tumor |
| MC | mass casualties; mast cell; Master of Surgery [Lat. Magister Chirurgiae]; maximum concentration; Med... |
| MLTC | mixed leukocyte-trophoblast culture; mixed lymphocyte tumor cell |
| MMMT | Malignant mixed Mullerian tumor |
|---|---|
| MMT | Mixed Mullerian Tumours |
| MD | Mullerian duct |
| PMDS | Persistent Mullerian Duct Syndrome |
| TNF alpha | Anti-tumour necrosis factor alpha |
acute monocytic leukemia
misdiagnosis
| mixed tumour, mullerian | A tumour, basically a carcinoma with a single sarcoma such as leiomyosarcoma or angiosarcoma or multiple sarcomas of uterine origin. The role of oestrogen has been postulated as a possible aetiological factor in this tumour. (holland et al., cancer medicine, 3d ed, p1703) (12 Dec 1998) |
|---|
| malignant mixed mullerian tumour | A sarcoma of the body of the uterus arising in older women, composed of more than one mesenchymal tissue, especially including striated muscle cells. Synonym: malignant mixed mullerian tumour. (05 Mar 2000) |
|---|---|
| mixed mesodermal tumour | A sarcoma of the body of the uterus arising in older women, composed of more than one mesenchymal tissue, especially including striated muscle cells. Synonym: malignant mixed mullerian tumour. (05 Mar 2000) |
| mixed tumour | A tumour composed of two or more varieties of tissue. (05 Mar 2000) |
| mixed tumour, malignant | A malignant tumour composed of more than one type of neoplastic tissue. (12 Dec 1998) |
| mixed tumour, mesodermal | A sarcoma of the body of the uterus arising in older women, composed of more than one mesenchymal tissue, especially including striated muscle cells. It is associated with previous pelvic radiation exposure in 20% of patients. (12 Dec 1998) |
| mixed tumour of salivary gland | A tumour composed of salivary gland epithelium and fibrous tissue with mucoid or cartilaginous areas. Synonym: pleomorphic adenoma. (05 Mar 2000) |
| mixed tumour of skin | <tumour> A benign tumour of sweat glands with a mucoid stroma showing cartilaginous metaplasia. Synonym: mixed tumour of skin. (05 Mar 2000) |
| persistent mullerian duct syndrome | <syndrome> Familial disorder with presence of fallopian tube, uterus, and testis in a male. Deficient mullerian inhibitory substance secondary to Sertoli cell defect. Synonym: hernia uteri inguinale. (05 Mar 2000) |
| mullerian | <anatomy> Of, pertaining to, or discovered by, Johannes Muller. <anatomy> Mullerian ducts, the sustentacular or connective-tissue fibres which form the framework of the retina. Source: Websters Dictionary (01 Mar 1998) |
| mullerian adenosarcoma | <tumour> A tumour of the uterus or ovaries, of low grade malignancy, characterised by benign appearing glands and a sarcomatous stroma. (05 Mar 2000) |
| mullerian duct | <radiology> FEMALE, fallopian tubes, uterus, vagina Male, appendix testis, prostatic utricle anomalies: mullerian agenesis most likely to be absent uterus and vagina, incomplete fusion most likely to be bicornuate/double uterus, double vagina, both associated with renal agenesis Cf: wolffian duct (12 Dec 1998) |
| mullerian ducts | Two ducts of the embryo which empty into the cloaca, and which in the female develop into vagina, uterus and oviducts; in the male they disappear except for the vestigial vagina masculina and the appendix testis. (12 Dec 1998) |
| mullerian inhibiting factor | A 535 amino acid glycoprotein secreted by the Sertoli cells of the testis. It is related to inhibin. Synonym: mullerian inhibiting factor. (05 Mar 2000) |
| mullerian inhibiting substance | A 535 amino acid glycoprotein secreted by the Sertoli cells of the testis. It is related to inhibin. Synonym: mullerian inhibiting factor. (05 Mar 2000) |
| mullerian regression factor | Mullerian duct inhibitory factor, a non-steroidal substance of foetal testicular origin that acts unilaterally to inhibit development of the paramesonephric (mullerian) ducts and acts with testosterone to promote development of the vas deferens and related structures. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|